Barclays PLC Has $2.07 Million Stock Holdings in BrightSpring Health Services, Inc. (NASDAQ:BTSG)

Barclays PLC reduced its stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 69.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 121,251 shares of the company's stock after selling 272,474 shares during the quarter. Barclays PLC owned approximately 0.07% of BrightSpring Health Services worth $2,066,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of BTSG. FMR LLC grew its position in BrightSpring Health Services by 21.6% in the 4th quarter. FMR LLC now owns 22,102,490 shares of the company's stock valued at $376,405,000 after acquiring an additional 3,933,303 shares in the last quarter. Vanguard Group Inc. increased its stake in BrightSpring Health Services by 5.3% in the fourth quarter. Vanguard Group Inc. now owns 5,325,093 shares of the company's stock valued at $90,686,000 after purchasing an additional 268,132 shares during the last quarter. Invesco Ltd. raised its stake in BrightSpring Health Services by 1.0% during the 4th quarter. Invesco Ltd. now owns 4,378,562 shares of the company's stock worth $74,567,000 after acquiring an additional 41,991 shares in the last quarter. Norges Bank purchased a new stake in BrightSpring Health Services in the fourth quarter valued at $26,065,000. Finally, Geode Capital Management LLC increased its position in shares of BrightSpring Health Services by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 1,311,204 shares of the company's stock worth $22,335,000 after purchasing an additional 6,990 shares in the last quarter.

Analyst Upgrades and Downgrades

Separately, UBS Group upped their target price on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. One research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $21.67.

BrightSpring Health Services Stock Performance

Shares of BTSG stock traded up $2.97 on Friday, hitting $20.87. 4,015,296 shares of the stock traded hands, compared to its average volume of 1,303,327. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97. BrightSpring Health Services, Inc. has a 1-year low of $10.15 and a 1-year high of $24.82. The company's fifty day moving average is $17.62 and its 200 day moving average is $18.52. The company has a market capitalization of $3.65 billion, a PE ratio of -80.27 and a beta of 2.02.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last announced its quarterly earnings data on Friday, May 2nd. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.10. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The business had revenue of $2.88 billion during the quarter, compared to analyst estimates of $2.74 billion. During the same quarter in the prior year, the firm posted $0.12 earnings per share. The company's revenue was up 25.9% on a year-over-year basis. On average, equities research analysts predict that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.